Impact of Body Mass Index on the Use of Prone Vigil and High-Flow Nasal Cannula in Pattients with COVID-19

被引:0
|
作者
Baeza Canales, Ricardo [1 ]
Leiva Arrue, Miryam [1 ]
Montecino Sepulveda, Maria [1 ]
Valenzuela Vasquez, Jorge [2 ]
Godoy Abarca, Loretto [2 ]
Gonzalez Concha, Nicole [2 ]
Munoz-Cofre, Rodrigo [3 ]
del Sol, Mariano [4 ,5 ]
Escobar-Cabello, Maximo [1 ]
机构
[1] Univ Catolica Maule, Fac Ciencias Salud, Escuela Kinesiol, Talca, Chile
[2] Hosp El Carmen Maipu, Santiago, Chile
[3] Univ La Frontera, Postdoctorado Ciencias Morfol, Temuco, Chile
[4] Univ La Frontera, Ctr Excelencia Estudios Morfol & Quirurg, Temuco, Chile
[5] Univ La Frontera, Doctorado Ciencias Morfol, Temuco, Chile
来源
INTERNATIONAL JOURNAL OF MORPHOLOGY | 2022年 / 40卷 / 04期
关键词
COVID-19; Body mass index; High-flow nasal cannula; RESPIRATORY-DISTRESS-SYNDROME; OBESITY; SUCCESS;
D O I
暂无
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
SUMMARY; The aim of the study was to determine whether body composition is a condition influencing the effect of awake prone positioning (APP) in patients with COVID-19 connected to high-flow nasal cannula (HFNC). We conducted a retrospective observational study and analyzed the therapeutic outcomes of 83 patients treated with HFNC in the medicine department of Hospital El Carmen (HEC), Santiago, Chile. The following information was obtained from the electronic clinical record (Florence clinical version 19.3) and the kinesic registry: i) patient history, ii) medical diagnosis, iii) body mass index (BMI), iv) characteristics of the APP and v) characteristics of the process of connection to CNAF. It was observed that there were significant differences in overweight and obese patients who used the PPV (p=0.001) through the ROX index (IROX) at the end of treatment with CNAF, occurring in the same way when evaluating the effects of the APP and in the PAFI in these same groups. In conclusion, BMI is a further aggravating factor that conditions the health of patients with COVID-19, and elevated BMI can negatively affect the treatment of these patients. On the other hand, the use of APP and CNAF proved to be effective in patients with COVID-19.
引用
收藏
页码:1088 / 1093
页数:6
相关论文
共 50 条
  • [31] Assessing the Use of Heated High Flow Nasal Cannula in COVID-19
    Fakhri, S.
    Balaban, E.
    Hippensteel, J. A.
    Jolley, S.
    Sippel, J.
    Peterson, R.
    Jin, Y.
    Kannappan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [32] PREDICTORS OF SPONTANEOUS PNEUMOMEDIASTINUM IN PATIENTS WITH COVID-19 AND ARDS ON HIGH-FLOW NASAL CANNULA
    Espinosa, Cynthia
    Morente, Laura Mendez
    Mansour, Ephraim H.
    Yousefzadeh, Michelle L.
    Muzaffarr, Zuleikha M.
    Salguero, Douglas
    Vianna, Sofia Durscki
    Quesada, Luisa D.
    Poli, Sergio
    Garcia, Hernando
    CHEST, 2022, 162 (04) : 1360A - 1361A
  • [33] High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19
    Palacios Chavarria, Adrian
    Salinas Lezama, Erika
    Gonzalez Navarro, Mauricio
    Valdez Vazquez, Rafael Ricardo
    Herrera Bello, Hector
    Lomelin Gascon, Julieta
    Morales Juarez, Linda
    Arboleya Avendano, Monica
    Ramirez Gonzalez, Luis Esteban
    Ville Benavides, Rodrigo
    Alvarez Wyssmann, Renate Victoria
    Sandoval Ortiz, Brenda
    Rodriguez de la Cerda, Mariana Lizbeth
    Moreno Castaneda, Lidia
    Alberto Martinez-Juarez, Luis
    Gallardo-Rincon, Hector
    Tapia-Conyer, Roberto
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [34] THE ROLE OF NONINVASIVE VENTILATION AND HIGH-FLOW NASAL CANNULA IN CRITICAL COVID-19 PNEUMONIA
    Perez-Gutierrez, Victor
    Ocrospoma, Sebastian
    Bhaskaran, Aditya
    Menon, Vidya
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 92 - 92
  • [35] HIGH-FLOW NASAL CANNULA IN PATIENTS WITH COVID-19: IS A COST-EFFECTIVE ALTERNATIVE?
    Alves Junior, J. M.
    Villagelin, D.
    Prota, F. E.
    Chrispim, A.
    Silva, C.
    Yamanaka, E.
    Tagliolatto, R.
    Beraldo, J.
    Kater, H.
    Gomes, J.
    Freitas, S.
    Borges, R.
    Macedo, A.
    VALUE IN HEALTH, 2022, 25 (01) : S106 - S107
  • [36] High-Flow Nasal Cannula Therapy in Patients With COVID-19: Predictive Response Factors
    Raboni, Sonia M.
    Neves, Valeria C.
    Silva, Rauce M.
    Breda, Giovanni L.
    Ceregato, Andressa C. L.
    Broza, Thayza P.
    de Oliveira, Glauber
    Melo-Diaz, Lucelia L.
    Braga, Claudia B.
    Carraro, Cesar F.
    Arroyo, Natalia C.
    Bardy, Rafael F.
    Devetak, Gisele F.
    Ozawa, Caroline M.
    Graf, Maria Esther
    Dias, Vitor L.
    Ducroquet, Marcelo A.
    Nunes, Daniella P.
    Sokoloski, Caroline S.
    Petterle, Ricardo R.
    RESPIRATORY CARE, 2022, 67 (11) : 1443 - 1451
  • [37] High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China
    Duan, Jun
    Zeng, Jia
    Deng, Puyu
    Ni, Zhong
    Lu, Rongli
    Xia, Wenxi
    Jing, Guoqiang
    Su, Xiaoping
    Ehrmann, Stephan
    Zhang, Wei
    Li, Jie
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [38] Use of high-flow nasal cannula in COVID-19 has improved effectiveness, safety and tolerability when applied in lateral position compared with prone positioning
    Sanz-Moncusi, M.
    Rossello-Sancho, J.
    Garcia-Alamino, J. M.
    INTENSIVE AND CRITICAL CARE NURSING, 2021, 66
  • [39] Predictors of high-flow nasal cannula failure in COVID-19 patients in a northern Peruvian hospital
    Calle-Pena, Sara Teresita
    Tavara, Edwin David Diaz
    Aguirre-Milachay, Edwin
    Leon-Figueroa, Darwin A.
    Valladares-Garrido, Mario J.
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [40] EFFICACY OF HIGH-FLOW NASAL CANNULA AND NONINVASIVE POSITIVE PRESSURE VENTILATION IN COVID-19 ARDS
    Madabhushi, Anirudh
    Roll, Brianna
    Wong, Steven
    Bagsic, Samantha
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 467 - 467